Current management strategy of nasopharyngeal carcinoma.
about
Early detection of nasopharyngeal carcinoma.Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective StudyDetection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinomaIntegrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study.An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.Primary tumors and tumor-like lesions of the eustachian tube: a systematic review of an emerging entity.Refractory nasopharyngeal carcinoma: positron emission tomography combined with computed tomography-guided 125I seed implantation therapy after repeated traditional radiochemotherapy.Management of pseudoaneurysms of the internal carotid artery in postirradiated nasopharyngeal carcinoma patients.S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.Relapse status as a prognostic factor in patients receiving salvage surgery for recurrent or residual nasopharyngeal cancer after definitive treatment.Large retropharyngeal abscess: a case of mistaken identity.Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience.MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4Nasopharyngeal carcinoma presenting as an inconspicuous primary lesion with extensive cavernous sinus involvement and temporal lobe extension: a case report and review of literatureThe expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance.[Treatment results of nasopharyngeal carcinoma in adults].The combination of curcumin and 5-fluorouracil in cancer therapy.Network-level dysconnectivity in patients with nasopharyngeal carcinoma (NPC) early post-radiotherapy: longitudinal resting state fMRI study.Incidence of late-onset pneumonia in patients after treatment with radiotherapy for nasopharyngeal carcinoma: A nationwide population-based study.Contribution of 18F-FDG PET/CT to Staging of Head and Neck Malignancies.Value of fused positron emission tomography CT in detecting primaries in patients with primary unknown cervical lymph node metastasis.Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.Identification of long non-coding RNA CCAT1 as an oncogene in nasopharyngeal carcinoma.TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
P2860
Q35055640-55972885-3B58-4722-BFC9-B0F541FE9B74Q35097767-C276376A-E6DC-48F8-A595-46E2E8B69520Q35974884-63AC94F6-AC23-416E-895E-97343EECA6AFQ35987088-923D55B9-E40B-4FAD-A27C-E5786A7ECAC8Q36373732-B5D16702-FCF9-4E60-8025-0F2EED432C07Q36544611-0CFE47E6-3ABD-46EC-B1A5-C372DA2C15B1Q37316834-5BCD81C3-02CF-4D63-88B3-287CEA089AF6Q37402090-02B66A31-BBD7-4B2D-9EA7-D32091400D8AQ37609486-A5864F2F-42F1-454F-9C19-49848A95ED4EQ37967349-EB898A0B-F6BA-4D41-9E41-BF8A70D93E55Q38110174-903264ED-7486-4ACE-B159-2748A675B37DQ38204921-3CE283EC-83B3-46E4-97B4-B7DEAD483DEBQ38748164-3A94FCD4-2933-4B0F-8B8F-00B0E4C74FD2Q38797778-7D1A9761-C568-4973-9594-73266640763AQ38956518-FF6D7C37-D748-46ED-B305-C1AACC1550F9Q39364642-13C36992-BBCD-434B-A6A9-E3DE21AD592FQ40990557-049F27C5-FF60-48C4-8589-C8CBE2C0BB9FQ42279542-EFD4225A-835B-4990-8CEF-02B189964425Q42687962-8DEF8521-E7AC-421E-BD39-F1118A610B23Q44599634-9493A751-36D5-4A8D-AEE2-92EA7E2004C5Q47577912-891741D7-BED8-4C5A-BAC9-F921FE0E190BQ47955620-4EF350C5-EF48-4CB8-AA03-618DC5734743Q48261895-C2E1525C-EDDD-4240-9C78-A33EA1F622F4Q49382278-C0B3517F-0F0C-4A42-BA32-D8DE3309DF2DQ53174767-961D4F8F-AF57-43C6-944A-277525C8EC3DQ55025647-697FB5EB-6829-4659-B4CF-79953918A0CAQ55669583-3E962D0E-161E-4D86-9F24-920427D5257CQ58801315-C2E16A36-7260-4D20-918B-1B104553547C
P2860
Current management strategy of nasopharyngeal carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Current management strategy of nasopharyngeal carcinoma.
@ast
Current management strategy of nasopharyngeal carcinoma.
@en
type
label
Current management strategy of nasopharyngeal carcinoma.
@ast
Current management strategy of nasopharyngeal carcinoma.
@en
prefLabel
Current management strategy of nasopharyngeal carcinoma.
@ast
Current management strategy of nasopharyngeal carcinoma.
@en
P2860
P356
P1476
Current management strategy of nasopharyngeal carcinoma
@en
P2093
Dora L W Kwong
P2860
P356
10.3342/CEO.2010.3.1.1
P577
2010-03-30T00:00:00Z